President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases.
The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.
"We're going to be able to make that drug available almost immediately," Trump said.
The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.
He also tempered the president's optimism about the still-untested solution.
"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."
New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.
"The therapies are something we could move on much faster potentially," Trump said.
He claimed the administration "slashed red tape" to develop new vaccines and therapies.
The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks.
"If we find that we need something, then we will do that," he said.
Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak.
The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.
"We continue our relentless effort to defeat the Chinese virus," Trump said.
U.S. Vice President Kamala Harris announced Thursday that the U.S. is investing more than $100 million in the Caribbean region to crack down on weapons trafficking, help alleviate Haiti’s humanitarian crisis and support climate change initiatives.
At Cleveland's Urban Kutz Barbershop, customers can flip through magazines as they wait, or help themselves to drug screening tests left out in a box on a table with a somber message: “Your drugs could contain fentanyl. Please take free test strips.”
President Joe Biden on Thursday condemned a wave of “cruel” and “callous” state legislation curbing the rights, visibility and health care access of LGBTQ+ people, while causing the community to feel under attack for being who they are.
Pat Robertson, a religious broadcaster who turned a tiny Virginia station into the global Christian Broadcasting Network, tried a run for president and helped make religion central to Republican Party politics in America through his Christian Coalition, has died. He was 93.
The Supreme Court on Thursday issued a surprising 5-4 ruling in favor of Black voters in a congressional redistricting case, ordering the creation of a second district with a large Black population.
Mike Pence opened his presidential bid with an unusually forceful critique of former President Donald Trump over Jan. 6, his temperament and abortion on Wednesday as he became the first vice president in modern history to challenge his former running mate.
Former New Jersey Gov. Chris Christie wasted no time going after Donald Trump while launching his presidential campaign on Tuesday, calling the former president and current Republican primary front-runner a “lonely, self-consumed, self-serving mirror hog" and arguing that he's the only one who can stop him.
Saying gender identity is real, a federal judge temporarily blocked portions of a new Florida law that bans transgender minors from receiving puberty blockers, ruling Tuesday that the state has no rational basis for denying patients treatment.
With concerns about misinformation spreading online, European Union officials want to more closely regulate artificial intelligence, and they're asking the world's biggest tech companies for help.
Sens. Elizabeth Warren, Ron Wyden, Ed Markey, and Mazie Hirono sent a letter to top officials at Twitter expressing their concerns over the platform's privacy policy.
